NCT03438357View on ClinicalTrials.gov

Evaluation of an Automatic Segmentation Software (Pixyl.Neuro) to Track Lesions in Multiple Sclerosis Patients Via Cerebral MRI

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

January 2, 2019

Primary Completion Date

July 6, 2022

Study Completion Date

July 6, 2022

Conditions

Multiple SclerosisClinically Isolated Syndrome

Interventions

OTHER

Analysis of cerebral MRI with automatic segmentation software

Pixyl.Neuro software versus manual analysis of lesions

Trial Locations (1)

30029

CHU Nimes, Nîmes

All Listed Sponsors

collaborator

Roche Pharma AG

INDUSTRY

lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT03438357 - Evaluation of an Automatic Segmentation Software (Pixyl.Neuro) to Track Lesions in Multiple Sclerosis Patients Via Cerebral MRI | Biotech Hunter | Biotech Hunter